Responses to parliamentary questions
Question from Deputy Ken O’Flynn - PQ 32775-26
Deputy O'Flynn asked about international reimbursement or access decisions in respect of omaveloxolone (Skyclarys). Read the HSE response.
From: Communications and public affairs
Published: May 2026
Updated: June 2026
Documents
Question from Deputy Ken O’Flynn - PQ 32775-26
PDF, 466KB, 3 pages
Summary
To ask the Minister for Health whether the HSE has considered international reimbursement or access decisions in respect of omaveloxolone, marketed as Skyclarys, including decisions in France, Italy, Germany or other comparable European countries, as part of the Irish reimbursement process.
This is a beta version - your feedback will help us to improve it